Cargando…
Coronavirus disease 2019 in Saudi Arabia: A nationwide real-world characterization study
BACKGROUND: On March 11th, 2020, The World Health Organization (WHO) declared that the COVID-19 is a pandemic due to its worldwide spread. The COVID-19 pandemic has extended its impact to Saudi Arabia. By mid-February 2021, The Kingdom of Saudi Arabia has reported more than 373,000 COVID-19 cases im...
Autores principales: | Alenzi, Khalidah A., Albalawi, Wafi F., Alanazi, Tahani S., Alanazi, Najah S., Alsuhaibani, Deemah S., Almuwallad, Nouf, Alshammari, Thamir M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235050/ https://www.ncbi.nlm.nih.gov/pubmed/35769341 http://dx.doi.org/10.1016/j.jsps.2022.02.015 |
Ejemplares similares
-
The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study
por: Alenzi, Khalidah A., et al.
Publicado: (2022) -
Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury
por: Alanazi, Najah S., et al.
Publicado: (2021) -
Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example
por: Alshammari, Thamir M., et al.
Publicado: (2020) -
Medication Error Concept and Reporting Practices in Saudi Arabia: A Multiregional Study Among Healthcare Professionals
por: Alshammari, Faizah M, et al.
Publicado: (2021) -
The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration’s Adverse Event Reporting System
por: Alsuhaibani, Deemah S., et al.
Publicado: (2023)